Alnylam Pharmaceuticals
ALNY
#586
Rank
$34.81 B
Marketcap
$269.95
Share price
-1.45%
Change (1 day)
61.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company